Interestingly, human subjects that carry both the LRRK2 G2019S variant and an additional variant in GBA1 do not have a worse clinical course of PD than those that carry a variant in either gene and, in fact, may have a beneficial effect with respect to cognitive decline [93]. The gene discussed is GBA1; the disease is Parkinson disease.